Recall Alert: Edwards Lifesciences Arterial Cannulae
Risk of wire exposure near the cannula tip
Edwards Lifesciences Arterial Cannula
Source: FDA
Edwards Lifesciences Recalls Arterial Cannulae Over Risk of Exposed Wire
Edwards Lifesciences has issued a Class I recall of certain arterial cannula devices due to the risk of wire exposure near the cannula tip, which could lead to serious injury or death if used.
Product Use
The recalled arterial cannulae are used in adult cardiopulmonary bypass procedures, delivering oxygenated blood from the extracorporeal circuit into the patient’s artery for up to six hours.
Why This Matters
The company discovered that a 3–4 mm segment of internal wire from the reinforcement coil can become exposed at the cannula tip. This defect may occur in both the OptiSite Arterial Perfusion Cannula and Femoral Arterial Cannula models, which share the same component materials.
Potential patient risks include:
- Major tissue damage
- Arterial puncture and bleeding
- Inadequate blood perfusion
- Hemolysis (destruction of red blood cells)
No injuries or deaths have been reported as of May 20, 2025.
Affected Products
|
Product Family |
Model Number |
UDI-DI |
|
OptiSite Arterial Perfusion Cannula |
OPTI16 |
00690103180558 |
|
OptiSite Arterial Perfusion Cannula |
OPTI18 |
00690103180565 |
|
Peripheral Femoral Arterial Cannula |
FEMII016A |
00690103031232 |
|
Peripheral Femoral Arterial Cannula |
FEMII016AS |
00690103168341 |
|
Peripheral Femoral Arterial Cannula |
FEMII018A |
00690103031256 |
|
Peripheral Femoral Arterial Cannula |
FEMII018AS |
00690103168358 |
What To Do
On May 16, 2025, Edwards Lifesciences began notifying customers via Field Corrective Action #192, advising the following:
- Stop using and remove any affected products from inventory
- Notify all relevant clinical staff at your facility
- No patient follow-up is required
- Work with your Edwards eCV representative to return affected products and receive a credit
- Distributors must notify their customers with the recall letter
Contact Information
If you have questions or need to report quality issues or adverse events, contact:
- Email: FCA_ECV@edwards.com
- Phone: 888-943-2783
Read the FDA recall announcement here.
FDA – Do Not Use Non-piercing Devices to Measure Blood Glucose
FDA Safety Communication On February 21, 2024 the U.S. Food and Drug Administration (FDA) issued a safety communication regarding the use of smartwatches or smart rings that claim to measure blood glucose levels without the need for skin piercing. Its cautionary...
Medos International Recalls CEREBASE DA Guide Sheath
Urgent Class I Recall Notice Medos International Sàrl has issued an urgent recall for the Cerenovus CEREBASE DA Guide Sheath, a neurovascular catheter commonly used in procedures requiring precise navigation and access to blood vessels in the brain. The recall was...